March 14th 2024
Oncology nurses can inform patients about the probability of identifying advanced neoplasia using stool-based screening tools.
Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma
View More
Live “Hot Seat”: Experts Face Your Hot-Button Questions on Maximizing PARP Inhibitors in Patients With CRPC
View More
Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?
View More
Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!
View More
Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer
View More
B-Cell Tumor Board: Rendering Real World Personalized Treatment Plans in CLL/SLL and MCL Through the Lens of Emerging BTKi Evidence
View More
Community Practice Connections™: Controversies and Conversations About HER2- Expressing Breast Cancer…Advances in Management of HER2-Low to -Positive Disease
View More
Show Me the Data™: Do We Have Sea Change for Novel Approaches in HR+/HER2- Breast Cancer? CDK, PI3K/AKT, ADC, and Next-Gen SERD Strategies Assessed
View More
Cancer Summaries and Commentaries™: Clinical Updates from Chicago in Breast Cancer
View More
8th Annual School of Nursing Oncology™
August 10, 2024
Register Now!
Cancer Summaries and Commentaries™: Clinical Updates in RCC from Chicago
View More
Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?
View More
How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities
View More
Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!
View More
Translating New Evidence into Treatment Algorithms from Frontline to R/R Multiple Myeloma: How the Experts Think & Treat
View More
Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?
View More
Dialogues With the Surgeon on Integration of Systemic Therapies in Perioperative Settings for NSCLC: Looking at EGFR, ALK, IO, and Beyond…
View More
The Next Wave in Biliary Tract Cancers: Leveraging Immunogenicity to Optimize Patient Outcomes in an Evolving Treatment Landscape
View More
The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…
View More
Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care
View More
Adherence to Diet and Activity Guidelines Means Substantial Reduction in Cancer Risk
June 26th 2016Researchers from the University of Arizona in Tucson and the American Cancer Society conducted a systematic literature review to examine associations between adherence to established cancer prevention guidelines and overall cancer incidence and mortality.
Buddy System: Why Dyadic Exercise May Make Sense for Survivors and Caregivers, Too
June 15th 2016Oncology nurses receive a steady stream of information on the benefits of exercise for health and wellness—not just a way to help prevent cancer and lower risk for the general population, but to improve quality of life and reduce the risk of recurrence for patients and survivors.
Amita Patel on the Benefits of a Multidisciplinary Care Team
May 12th 2016Amita Patel, NPC, Regional Cancer Care Associates, Central Jersey Division, talks about benefits of a multidisciplinary care team and some issues that providers should be aware of when treating patients undergoing chemotherapy.
Nightly Fasting Found Beneficial to Reduce Breast Cancer Recurrence
May 2nd 2016A study of more than 2400 women with early-stage breast cancer has found that those who fasted 13 hours or more at night reduced their risk of breast cancer recurrence, findings that suggest prolonging the nightly fasting interval may offer a relatively safe nonpharmacologic way for women with early breast cancer to lower their risk of disease recurrence.
Weight-Loss Intervention Improves Fitness in Cancer Survivors
January 19th 2016Mounting research continues to show increased risk of cancer recurrence and death in obese individuals, but findings of a new study highlight the benefits of weight-loss interventions for overweight and obese cancer survivors.
For Average Women, Mammograms Should Start at Age 50, Recommends USPSTF
January 12th 2016Using an individualized approach to decide whether asymptomatic women under age 50 should have mammograms is at the center of the final screening guidelines published by the US Preventive Services Task Force (USPSTF), but the group
Alison Morris on Screening for Distress and Nurse-Led Algorithms
November 18th 2015Alison Morris, RN, OCN, a Hematology/Oncology nurse practitioner at Stanford Health Care, discusses screening patients with cancer for emotional and physical distress as well as developing a nurse-led algorithm to categorize distress.
American Cancer Society Raises Age to 45 for First Mammogram
October 21st 2015The American Cancer Society (ACS) has revised its breast cancer screening guidelines, recommending that women at an average risk of breast cancer receive a mammography annually starting at age 45-5 years later than previous recommendations formulated in 2003.
Promoting Patients' Nutritional Health During and After Treatment
October 7th 2015Good nutrition is an important component in any patient's cancer journey. A healthy diet is needed to maintain appropriate body weight and strength, absorb the proper nutrients, keep body tissue healthy, and fight infection.
Mark Lazenby on the Screening for Psychosocial Distress Program
September 8th 2015Mark Lazenby, PhD, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses the Screening for Psychosocial Distress Program, which was launched in 2014 by APOS in partnership with Yale School of Nursing.